Pascal Reber
Chairman at Entreprendre Pour Apprendre /Rhone Alpes/
Profile
Pascal Reber is currently the Chairman and Treasurer at Entreprendre Pour Apprendre.
Previously, he held positions as Chairman-Supervisory Board at Amoéba SA, Chairman at Association Des Fabricants De L’Industrie Pharmaceutique De RA, and Vice President & General Director at Genzyme Corp.
He obtained an undergraduate degree from Ecole Nationale d'Ingénieurs de Metz.
Pascal Reber active positions
| Companies | Position | Start |
|---|---|---|
| Entreprendre Pour Apprendre /Rhone Alpes/ | Chairman | - |
| Entreprendre Pour Apprendre | Treasurer | - |
Former positions of Pascal Reber
| Companies | Position | End |
|---|---|---|
| AMOÉBA | Chairman | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| Association Des Fabricants De L’Industrie Pharmaceutique De RA | Chairman | - |
Training of Pascal Reber
| Ecole Nationale d'Ingénieurs de Metz | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMOÉBA | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Entreprendre Pour Apprendre | |
| Entreprendre Pour Apprendre /Rhone Alpes/ | |
| Association Des Fabricants De L’Industrie Pharmaceutique De RA |
- Stock Market
- Insiders
- Pascal Reber
